As already mentioned above, there are many reported cancer cases with high NFE2L2 expression, some of which are associated with increased tumourigenesis [36, 37] and therapy resistance [38–43] and a few correlated with poor survival [22, 44, 45]. Here, NFE2L2 is linked to cancer.